ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 114 filers reported holding ACCELERON PHARMA INC in Q4 2014. The put-call ratio across all filers is 0.52 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,571,009 | -6.6% | 12,519 | +1.0% | 0.01% | -33.3% |
| Q1 2021 | $1,681,157 | +2.3% | 12,397 | -28.1% | 0.02% | -25.0% |
| Q2 2020 | $1,643,000 | +6.3% | 17,250 | +0.3% | 0.02% | +17.6% |
| Q1 2020 | $1,546,000 | +496.9% | 17,205 | +252.5% | 0.02% | +750.0% |
| Q4 2019 | $259,000 | -14.2% | 4,881 | -36.1% | 0.00% | 0.0% |
| Q3 2019 | $302,000 | -64.8% | 7,637 | -56.6% | 0.00% | -60.0% |
| Q4 2015 | $858,000 | +28500.0% | 17,600 | +19900.0% | 0.01% | – |
| Q2 2015 | $3,000 | -99.9% | 88 | -99.9% | 0.00% | -100.0% |
| Q1 2015 | $4,127,000 | +1.4% | 108,413 | +3.7% | 0.02% | 0.0% |
| Q4 2014 | $4,071,000 | – | 104,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |